Progesterone in Gender Affirming Hormone Therapy Study
ConditionTransgender Women
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexMale
Age18-60
SponsorEmory University
About this trial
This study aims to study the effects of Oral Progesterone in Transgender Women. The primary goal is to study the effect of progesterone on psychological distress and secondarily on sleep quality, breast size, quality of life and gender congruence and cardiovascular risk.
Eligibility criteria
Qualifiers
None
Disqualifiers
Peanut allergy
Liver disease (liver enzyme elevations and/or evidence of acute or chronic hepatitis). In our lab, the upper limit of normal for aspartate aminotransferase (AST) is 39, and the upper limit of normal for alanine aminotransferase (ALT) is 52.
Stage 4/5 chronic kidney disease
Congestive heart failure
Trial design
Treatments tested in this trial
- Placebo
- Progesterone
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov